본문 바로가기
bar_progress

Text Size

Close

PCL Participates in Morocco National Health Project Worth 670 Billion KRW

Morocco Royal Medical College 'Mohamed 6' Joint Research and MOU Signing

PCL Participates in Morocco National Health Project Worth 670 Billion KRW Yashin Akashumar, Senior Advisor to the Moroccan Ministry of Welfare, is undergoing an antibody test at the PCIL Research Building.


[Asia Economy Reporter Kim Young-won] PCL announced on the 20th that it has decided to participate in Morocco's national health project through a memorandum of understanding (MOU) with the Moroccan Ministry of Health.


This project aims to build an in vitro diagnostics R&D and manufacturing center in Morocco for blood screening, multi-cancer screening, and autoimmune testing. It is a project to establish a core biotechnology hub that integrates pharmaceutical research, clinical development, manufacturing, and marketing to meet the medical-related demands of the African continent, with a total budget of approximately 670 billion KRW. The project will be led by 'Mohamed VI' University, Morocco's royal medical school.


The Moroccan government plans to establish regional and international centers for in vitro diagnostics, vaccine, and biotherapeutics manufacturing through this project, aiming to enhance research capabilities in these fields and biotechnology in the mid to long term.


Representatives from Morocco also visited Korea for the project. The visiting delegation included Dr. Yassin Akashmar, senior advisor to the Ministry of Health; Shakib Nejari, president of Mohamed VI Royal Medical University; Vice Presidents Said Olbasha and Jelila Benhammou; and the Moroccan Ambassador to Korea, Shafik Rashadi.


Dr. Yassin Akashmar said, "This project is intended to improve access to in vitro diagnostics and other medical services for the Moroccan people. PCL will play a key role in the field of in vitro diagnostics and Morocco's government digital health project through close cooperation with the Moroccan government."


So-yeon Kim, CEO of PCL, stated, "Africa, along with South America, is a region with very poor medical infrastructure where mobile medical diagnostic services are urgently needed. Especially with the widespread prevalence of malaria and various sexually transmitted diseases, it is urgent to establish medical services that can quickly diagnose and treat related diseases. We are confident that PCL's in vitro diagnostic system will be helpful to the residents in this region."


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top